Gold Standard Diagnostics, LLC

Gold Standard Diagnostics, LLC (Gold Standard Diagnostics Division), headquartered in Davis, California, manufactures diagnostic laboratory equipment, reagents, and consumables for federal healthcare agencies, operating exclusively as a prime contractor on small-dollar purchase orders and blanket purchase agreements. The company is a for-profit limited liability company and small business; it competes under total small business set-asides where applicable but does not hold certifications as an 8(a) firm, HUBZone, SDVOSB, or WOSB entity.

The vendor's capability portfolio centers on diagnostic equipment manufacturing, laboratory reagent supply, and equipment maintenance for federal healthcare programs. Representative work includes a $52.5 thousand purchase order from the Indian Health Service (IHS) in July 2023 for a Gold Standard Analyzer PM for Phoenix Indian Medical Center; a $49.4 thousand IHS order in July 2023 for an agglutination processor with reagents for rapid plasma reagin (RPR) syphilis testing at the Chinle Laboratory; a $55.2 thousand IHS purchase order from February 2024 for FY2024 RPR reagents and consumables at Chinle; a $42 thousand Food and Drug Administration purchase order from August 2024 under total small business set-aside for a ThunderBolt ELISA Analyzer supporting allergen detection method validation; and a $145 thousand Veterans Integrated Service Network 6 lease agreement from December 2025 for a Rapid Plasma Processor System for syphilis testing, performed in Davis, California.

Customer concentration is heavily skewed toward IHS. The Indian Health Service accounts for 12 of 19 recent awards (63% of award count) and $759 thousand of combined potential value (63% of the portfolio dollar total). The remaining agencies—the Environmental Protection Agency Region 8, Veterans Integrated Service Networks 6 and 8, the Centers for Disease Control and Prevention Pittsburgh, and the Air Force Materiel Command Test Center—collectively hold 7 awards valued at $445 thousand. The top five customers by either metric cover 89% to 94% of the portfolio. IHS dominates in both rankings without tension between award frequency and dollars.

Gold Standard Diagnostics holds a single-award Blanket Purchase Agreement with IHS (contract 75H71223A00007) established May 18, 2023, with a $249 thousand ceiling running through September 2028. This IDV has generated four BPA call task orders worth $114 thousand combined. The vendor operates only against this single parent vehicle and does not sub-award; 100% of recent work is prime contract activity.

Activity has been episodic. Awards peaked in 2023 with five orders, fell to three in 2024, recovered to four in 2025, and one award has appeared in 2026 year-to-date. Three awards (combined potential value $103 thousand) reach ultimate completion within the next twenty-four months, creating moderate recompete exposure, primarily in the IHS relationship. The vendor has not expanded into additional customer agencies, sub-awards, or government-wide vehicles. Performance locations include Davis, California (administrative and equipment delivery), Phoenix and Chinle, Arizona (IHS facility support), and Denver, Colorado (EPA Region 8 equipment repair).

A sales, marketing, distribution and automation manafacturing company that provides medical devices/diagnostic assays to major laboratories and hospitals throughout the U.S.